For patients with type 2 diabetes, stopping GLP-1 therapy usually leads to worsening glycemic control
Wellstar provides primary care for the LGBTQ community, including wellness exams, chronic disease management, virtual appointments and other health screenings
Another official page lists $499 at higher doses, so checkout must confirm the amount
Similarly, the FDA has approved a number of injectable GLP-1s for type 2 diabetes, such as Ozempic (semaglutide), Mounjaro (tirzepatide), and (semaglutide), an oral GLP-1 medication for blood sugar control in people with type 2 diabetes
Reported side effects may include nausea, vomiting, diarrhea, and constipation, among others
You might: Prefer not to take injections Want a daily routine that fits more naturally into your morning Find it easier to travel or store tablets compared to refrigerated injection pens or vials Need to change medications due to insurance coverage or availability Experience injection site issues with injectable GLP-1s Switching to an oral GLP-1 may offer more convenience, but its not the right option for everyone